Gwadry-Sridhar Femida H. 4
4 · Medpace Holdings, Inc. · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
Medpace (MEDP) Director Femida Gwadry‑Sridhar Receives Option Award
What Happened
Femida H. Gwadry‑Sridhar, a director of Medpace Holdings, Inc. (MEDP), received a derivative award on May 15, 2026 covering 1,110 shares. The reported acquisition price is $0.00, indicating a grant of equity compensation (an option or similar derivative) rather than an open‑market purchase.
Key Details
- Transaction date: 2026-05-15; Form 4 filed: 2026-05-18 (timely filing).
- Transaction type/code: A (Grant/Award/Other acquisition of a derivative security).
- Shares/units: 1,110 derivative shares; reported price $0.00.
- Shares owned after the transaction: not specified in the provided filing data.
- Footnote: the option vests on the earlier of (i) the day before the first annual meeting after the grant or (ii) the first anniversary of the grant date, provided continued service on the board through the vesting date.
Context
This was an equity award (derivative) granted as compensation to a director, not a cash purchase or sale. Such grants are common for board compensation and vest over time; they do not indicate an immediate market purchase or sale of stock.
Insider Transaction Report
Form 4
Gwadry-Sridhar Femida H.
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-05-15+1,110→ 1,110 totalExercise: $415.27Exp: 2033-05-15→ Common Stock (1,110 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Femida H. Gwadry-Sridhar|2026-05-18